| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.13▲ | 4.13▲ | 4.13▲ | 4.01▲ | 3.75▲ |
| MA10 | 4.11▲ | 4.08▲ | 4.07▲ | 3.86▲ | 3.48▲ |
| MA20 | 4.05▲ | 3.98▲ | 3.97▲ | 3.55▲ | 3.48▲ |
| MA50 | 3.97▲ | 3.87▲ | 3.74▲ | 3.34▲ | 4.47▼ |
| MA100 | 3.86▲ | 3.55▲ | 3.50▲ | 3.45▲ | N/A |
| MA200 | 3.55▲ | 3.36▲ | 3.34▲ | 3.63▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.004▲ | -0.001▼ | 0.074▲ | N/A |
| RSI | 57.875▲ | 59.044▲ | 60.042▲ | 66.013▲ | N/A |
| STOCH | 76.050 | 80.456▲ | 82.374▲ | 82.779▲ | 67.294 |
| WILL %R | -23.810▲ | -16.393▲ | -16.393▲ | -11.196▲ | -9.756▲ |
| CCI | 57.501 | 88.362 | 91.545 | 85.616 | 118.651▲ |
|
Thursday, December 05, 2019 10:02 AM
Aptinyx (NASDAQ:APTX) initiates a Phase 2 clinical study of its NMDA receptor modulator, NYX-458, for the treatment of mild cognitive impairment associated with Parkinson’s disease. Top-line data from ...
|
|
Wednesday, December 04, 2019 08:00 AM
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
|
|
Monday, December 02, 2019 12:54 PM
Wall Street analysts forecast that Aptinyx Inc (NASDAQ:APTX) will post sales of $950,000.00 for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/12/19 | 4.17 | 4.20 | 4.02 | 4.09 | 42,758 |
| 06/12/19 | 4.02 | 4.2186 | 4.00 | 4.15 | 162,050 |
| 05/12/19 | 3.96 | 4.025 | 3.85 | 3.99 | 87,289 |
| 04/12/19 | 3.86 | 4.04 | 3.78 | 3.98 | 75,400 |
| 03/12/19 | 3.80 | 3.99 | 3.64 | 3.85 | 91,300 |
| 02/12/19 | 4.05 | 4.05 | 3.84 | 3.85 | 75,300 |
| 29/11/19 | 3.91 | 4.14 | 3.79 | 4.06 | 41,300 |
| 27/11/19 | 3.59 | 4.00 | 3.59 | 3.89 | 198,100 |
| 26/11/19 | 3.29 | 3.64 | 3.29 | 3.51 | 197,000 |
| 25/11/19 | 3.24 | 3.25 | 3.13 | 3.25 | 102,400 |
|
|
||||
|
|
||||
|
|